规范治疗在改善慢性支气管炎患者临床症状中的效果观察  

Effect Observation of Standard Treatment in Improving Clinical Symptoms of Chronic Bronchitis Patients

作　　者：李倩影[1] 肖桂贤[1] 郭福莹 LI Qianying;XIAO Guixian;GUO Fuying(The Second Affiliated Hospital of Shenyang Medical College,Shenyang 110035,China)

机构地区：[1]沈阳医学院附属第二医院,辽宁沈阳110035

出　　处：《中国医药指南》2021年第1期112-113,共2页Guide of China Medicine

摘　　要：目的对规范治疗在改善慢性支气管炎患者临床症状中的效果进行观察。方法在笔者所在医院2018年3月至2019年1月收治的慢性支气管炎患者中选择70例展开研究,患者对于研究内容均知情同意且符合临床对于疾病的诊断标准,采用随机数表法将患者平均分为两组,每组包括患者35例。观察组和对照组分别接受规范治疗和常规治疗,对比两组患者的治疗效果及不良反应发生情况。结果观察组患者整体治疗有效率94.29%,显著高于对照组患者的71.43%(P<0.05),观察组患者不良反应发生率5.71%显著低于对照组的20.00%(P<0.05)。结论针对慢性支气管炎患者采取规范治疗,能够显著提升治疗效果并降低不良反应发生率,值得临床推广使用。Objective to observe the effect of standard treatment in improving the clinical symptoms of chronic bronchitis patients.Methods Seventy patients with chronic bronchitis admitted to the author’s hospital from March 2018 to January 2019 were selected for the study.The patients had informed consent to the research content and met the clinical diagnostic criteria for the disease.The random number table method was used to average the patients divided into two groups,each group includes 35 patients.The observation group and the control group received standard treatment and conventional treatment respectively,and the treatment effects and adverse reactions of the two groups were compared.Results The overall effective rate of the observation group was 94.29%,which was significantly higher than 71.43%of the control group(P<0.05),and the incidence of adverse reactions in the observation group was 5.71%,which was significantly lower than 20.00%of the control group(P<0.05).Conclusion Standardized treatment for patients with chronic bronchitis can significantly improve the treatment effect and reduce the incidence of adverse reactions,which is worthy of clinical application.

关 键 词：规范治疗 慢性支气管炎 临床症状 效果 

分 类 号：R562.21[医药卫生—呼吸系统]